Elan Drug Technologies

Navigation

• Home
• Careers
• Sitemap

Trademarks

Trademark references
Other than those listed below, all trademarks are owned by Elan Pharma International Ltd.

Adalat® CC registered trademark of Bayer Corporation; Afeditab® is a registered trademark of Watson Pharmaceuticals Inc; Ampyra™ trademark of Acorda Therapeutics Inc; Avinza® registered trademark of King Pharmaceuticals Inc; BiDil® registered trademark of NitroMed Inc; Cardizem® registered trademark of Biovail Laboratories Incorporated; Emend® registered trademark of Merck & Co Inc;  Focalin®  and Ritalin®  registered trademarks of  Novartis AG; Herbesser® registered trademark owned by Tanabe; Invega® Sustenna® is a trademark of Johnson & Johnson family of companies; Luvox CR® is a registered trademark of Abbott Products Inc; Megace® registered trademark of Bristol-Myers Squibb Company licensed to Par Pharmaceuticals, Inc;  Morphelan® trademark of Elan Corporation plc, Naprelan® Registered trademark owned by Elan Corporation plc;  Rapamune® registered trademark owned by Wyeth Pharmaceuticals;  Seldane® is a registered trademark  of Hoechst Marion Roussel Inc. (now sanofi aventis); Taxotere® registered trademark of Aventis Pharma SA; Theodur™ is a trademark of Mitsubishi Tanabe in Japan; TriCor® registered trademark of Fournier Industrie et Sante SA; Verelan® registered trademark owned by Elan Corporation plc; Zanaflex capsules® registered trademark of Acorda Therapeutics Inc, Zolip™ is a trademark of Solvay SA.